8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist.
Standard
8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist. / Kirchberger, Tanja; Moreau, Christelle; Wagner, Gerd; Fliegert, Ralf; Siebrands, Cornelia; Nebel, Merle; Schmid, Frederike; Harneit, Angelika; Francesca, Odoardi; Flügel, Alexander; Potter, Barry; Guse, Andreas H.
In: BIOCHEM J, 2009.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist.
AU - Kirchberger, Tanja
AU - Moreau, Christelle
AU - Wagner, Gerd
AU - Fliegert, Ralf
AU - Siebrands, Cornelia
AU - Nebel, Merle
AU - Schmid, Frederike
AU - Harneit, Angelika
AU - Francesca, Odoardi
AU - Flügel, Alexander
AU - Potter, Barry
AU - Guse, Andreas H.
PY - 2009
Y1 - 2009
N2 - Cyclic ADP-ribose (cADPR) is a universal Ca2+ mobilizing second messenger. In T cells cADPR is involved in sustained Ca2+ release and also in Ca2+ entry. Potential mechanisms for the latter include either capacitative Ca2+ entry secondary to store depletion by cADPR or direct activation of the non-selective cation channel transient receptor potential - melastatin type 2 (TRPM2). Here we characterize the molecular target of the newly-described membrane-permeant cADPR agonist 8-bromo-cyclic inosine diphosphoribose (8-Br-N1-cIDPR). 8-Br-N1-cIDPR evoked Ca2+ signalling in the human T-lymphoma cell line Jurkat and in primary rat T-lymphocytes. Ca2+ signalling induced by 8-Br-N1-cIDPR consisted of Ca2+ release and Ca2+ entry. While Ca2+ release was sensitive to both the ryanodine receptor blocker ruthenium red and the cADPR antagonist 8-bromo-cyclic adenosine diphosphoribose (8-Br-cADPR), Ca2+ entry was inhibited by the Ca2+ entry blockers Gd3+ and SKF 96365 as well as by 8-Br-cADPR. To unravel a potential role for TRPM2 in sustained Ca2+ entry evoked by 8-Br-N1-cIDPR, TRPM2 was overexpressed in HEK 293 cells. However, though activation by hydrogen peroxide was enhanced dramatically in those cells, Ca2+ signalling induced by 8-Br-N1-cIDPR was almost unaffected. Similarly, direct analysis of TRPM2 currents did not reveal activation or co-activation of TRPM2 by 8-Br-N1-cIDPR. In summary, the sensitivity to the Ca2+ entry blockers Gd3+ and SKF 96365 is in favour of the concept of capacitative Ca2+ entry secondary to store depletion by 8-Br-N1-cIDPR. Taken together, 8-Br-N1-cIDPR appears to be the first cADPR agonist affecting Ca2+ release (and secondary Ca2+ entry), but without effect on TRPM2.
AB - Cyclic ADP-ribose (cADPR) is a universal Ca2+ mobilizing second messenger. In T cells cADPR is involved in sustained Ca2+ release and also in Ca2+ entry. Potential mechanisms for the latter include either capacitative Ca2+ entry secondary to store depletion by cADPR or direct activation of the non-selective cation channel transient receptor potential - melastatin type 2 (TRPM2). Here we characterize the molecular target of the newly-described membrane-permeant cADPR agonist 8-bromo-cyclic inosine diphosphoribose (8-Br-N1-cIDPR). 8-Br-N1-cIDPR evoked Ca2+ signalling in the human T-lymphoma cell line Jurkat and in primary rat T-lymphocytes. Ca2+ signalling induced by 8-Br-N1-cIDPR consisted of Ca2+ release and Ca2+ entry. While Ca2+ release was sensitive to both the ryanodine receptor blocker ruthenium red and the cADPR antagonist 8-bromo-cyclic adenosine diphosphoribose (8-Br-cADPR), Ca2+ entry was inhibited by the Ca2+ entry blockers Gd3+ and SKF 96365 as well as by 8-Br-cADPR. To unravel a potential role for TRPM2 in sustained Ca2+ entry evoked by 8-Br-N1-cIDPR, TRPM2 was overexpressed in HEK 293 cells. However, though activation by hydrogen peroxide was enhanced dramatically in those cells, Ca2+ signalling induced by 8-Br-N1-cIDPR was almost unaffected. Similarly, direct analysis of TRPM2 currents did not reveal activation or co-activation of TRPM2 by 8-Br-N1-cIDPR. In summary, the sensitivity to the Ca2+ entry blockers Gd3+ and SKF 96365 is in favour of the concept of capacitative Ca2+ entry secondary to store depletion by 8-Br-N1-cIDPR. Taken together, 8-Br-N1-cIDPR appears to be the first cADPR agonist affecting Ca2+ release (and secondary Ca2+ entry), but without effect on TRPM2.
M3 - SCORING: Zeitschriftenaufsatz
JO - BIOCHEM J
JF - BIOCHEM J
SN - 0264-6021
ER -